JP2009523777A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009523777A5 JP2009523777A5 JP2008550839A JP2008550839A JP2009523777A5 JP 2009523777 A5 JP2009523777 A5 JP 2009523777A5 JP 2008550839 A JP2008550839 A JP 2008550839A JP 2008550839 A JP2008550839 A JP 2008550839A JP 2009523777 A5 JP2009523777 A5 JP 2009523777A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- deoxyactagardine
- alkyl
- compound
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0600928.6 | 2006-01-17 | ||
| GBGB0600928.6A GB0600928D0 (en) | 2006-01-17 | 2006-01-17 | Improvements relating to lantibiotics |
| PCT/GB2007/000138 WO2007083112A2 (en) | 2006-01-17 | 2007-01-17 | Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009523777A JP2009523777A (ja) | 2009-06-25 |
| JP2009523777A5 true JP2009523777A5 (https=) | 2010-03-04 |
| JP5219837B2 JP5219837B2 (ja) | 2013-06-26 |
Family
ID=35998187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008550839A Expired - Fee Related JP5219837B2 (ja) | 2006-01-17 | 2007-01-17 | Ａ．ガルバジネンシスおよびａ．リグリエに由来するランチビオティック生合成遺伝子クラスター |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US7989416B2 (https=) |
| EP (2) | EP1979375B9 (https=) |
| JP (1) | JP5219837B2 (https=) |
| KR (1) | KR101573536B1 (https=) |
| CN (1) | CN101389641B (https=) |
| AT (1) | ATE534659T1 (https=) |
| AU (1) | AU2007206769B2 (https=) |
| BR (1) | BRPI0706525A2 (https=) |
| CA (1) | CA2637315A1 (https=) |
| CY (1) | CY1112559T1 (https=) |
| DK (1) | DK1979375T3 (https=) |
| ES (1) | ES2378090T3 (https=) |
| GB (1) | GB0600928D0 (https=) |
| IL (1) | IL192446A0 (https=) |
| MX (1) | MX2008009047A (https=) |
| NZ (1) | NZ569486A (https=) |
| PL (1) | PL1979375T3 (https=) |
| PT (1) | PT1979375E (https=) |
| SI (1) | SI1979375T1 (https=) |
| WO (1) | WO2007083112A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0600928D0 (en) | 2006-01-17 | 2006-02-22 | Novacta Biosystems Ltd | Improvements relating to lantibiotics |
| GB0714030D0 (en) * | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
| GB0714029D0 (en) * | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | Lantibiotic-based compounds having antimicrobial activity |
| CA2749278A1 (en) * | 2009-01-14 | 2010-07-22 | Novacta Biosystems Limited | Deoxyactagardine derivatives |
| GB0900599D0 (en) | 2009-01-14 | 2009-02-18 | Novacta Biosystems Ltd | Treatment |
| CN102388060B (zh) * | 2009-02-04 | 2014-09-10 | 诺瓦克塔生物系统有限公司 | 阿肽加定衍生物 |
| CA2789164A1 (en) | 2010-02-02 | 2011-08-11 | Novacta Biosystems Limited | Lantibiotic salts |
| GB201001688D0 (en) | 2010-02-02 | 2010-03-17 | Novacta Biosystems Ltd | Compounds |
| EA201291461A1 (ru) | 2010-07-14 | 2013-08-30 | Новакта Биосистемс Лимитед | Состав, содержащий лантибиотик типа b |
| GB201013508D0 (en) | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Compounds |
| GB201013507D0 (en) | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Compounds |
| GB201013513D0 (en) * | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Formulations |
| GB201013509D0 (en) | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Compounds |
| EP2925342A4 (en) * | 2012-11-30 | 2016-07-06 | Naicons Srl | NOVEL LANTIBIOTIC DERIVATIVES AND PREPARATION METHOD THEREOF |
| CN103483433B (zh) * | 2013-09-10 | 2015-05-27 | 中国科学院微生物研究所 | 一种新型高效的羊毛硫细菌素cerecidin及其应用 |
| CN106188253B (zh) * | 2016-08-26 | 2020-08-18 | 上海交通大学 | 抗菌肽Lexapeptide及其制备方法和用途 |
| CN113777306A (zh) * | 2020-06-09 | 2021-12-10 | 首都医科大学附属北京世纪坛医院 | 尿液果糖二磷酸醛缩酶b及其多肽片段在烧伤中的应用 |
| CN115637247B (zh) * | 2021-07-20 | 2026-02-24 | 中国科学院微生物研究所 | 生物氧化脱硫的盐单胞菌工程菌株及其全细胞催化脱硫方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| GB8507528D0 (en) | 1985-03-22 | 1985-05-01 | Lepetit Spa | Basis monocarboxyamide derivatives |
| US5304540A (en) | 1988-06-22 | 1994-04-19 | Applied Microbiology, Inc. | Pharmaceutical bacteriocin compositions and methods for using the same |
| IN167138B (https=) | 1988-08-17 | 1990-09-01 | Hoechst India | |
| GB8926639D0 (en) | 1989-11-24 | 1990-01-17 | Agricultural & Food Res | Delayed release formulations |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| IT1260505B (it) | 1992-06-01 | 1996-04-09 | Poli Ind Chimica Spa | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
| IL107887A (en) | 1992-12-08 | 2003-07-06 | Ambi Inc | Stabilized lanthionine containing bacteriocin compositions |
| US5512269A (en) | 1993-06-09 | 1996-04-30 | Burroughs Wellcome, Co. | Method of treating retained pulmonary secretions |
| EP0700998B1 (en) | 1994-09-12 | 2003-11-26 | Aventis Pharma Deutschland GmbH | Recombinant mersacidin and a method for production |
| NZ311535A (en) | 1995-06-23 | 2001-05-25 | Ambi Inc | A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US5958873A (en) | 1997-06-09 | 1999-09-28 | University Of Cincinnati | Oral formulation for treatment of bacteria-induced diseases of the colon |
| US5985823A (en) | 1997-06-09 | 1999-11-16 | Ambi Inc. | Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| DE19745583A1 (de) * | 1997-10-15 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben |
| US6569830B1 (en) | 1999-03-05 | 2003-05-27 | Ambi, Inc. | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
| KR100786927B1 (ko) | 2000-06-28 | 2007-12-17 | 스미스클라인비이참피이엘시이 | 습식 분쇄방법 |
| GB0110432D0 (en) * | 2001-04-27 | 2001-06-20 | Plant Bioscience Ltd | Lantibiotic production |
| WO2002103010A1 (en) | 2001-06-14 | 2002-12-27 | Plant Bioscience Limited | Methods and materials for targeted gene disruption in actinomycete bacteria |
| US6861236B2 (en) | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
| AU2003275129A1 (en) | 2002-10-10 | 2004-05-04 | Molichem Medicines, Inc. | Nucleic acids encoding duramycin |
| US7351687B2 (en) | 2003-07-18 | 2008-04-01 | Vicuron Pharmaceuticals, Inc. | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| ES2281808T3 (es) | 2003-07-18 | 2007-10-01 | Vicuron Pharmaceuticals, Inc. | Antibiotico 107891, sus factores a1 y a2, composiciones y sales farmaceuticamente aceptables y uso del mismo. |
| WO2005079508A2 (en) * | 2004-02-17 | 2005-09-01 | Cancervax Corporation | Method and composition for angiogenesis inhibition |
| GB0406870D0 (en) | 2004-03-26 | 2004-04-28 | Novacta Biosystems Ltd | Improvements relating to the production of lantibiotics |
| WO2007036706A1 (en) | 2005-09-27 | 2007-04-05 | Novacta Biosystems Limited | Variants of the lantibiotic mersacidin and their use |
| GB0600928D0 (en) | 2006-01-17 | 2006-02-22 | Novacta Biosystems Ltd | Improvements relating to lantibiotics |
| CN101595133B (zh) | 2006-10-27 | 2012-11-14 | 比利时胶囊公司 | 羟丙基甲基纤维素硬胶囊及制备方法 |
| CA2690267A1 (en) | 2007-06-12 | 2008-12-18 | The University Of British Columbia | Small cationic antimicrobial peptides |
| GB0714029D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | Lantibiotic-based compounds having antimicrobial activity |
| GB0714030D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
| KR20110086582A (ko) | 2008-11-24 | 2011-07-28 | 센티넬라 파마세티컬즈, 인크. | 항균활성이 강화된 란티바이오틱 카르복시아미드 유도체 |
| CA2749278A1 (en) | 2009-01-14 | 2010-07-22 | Novacta Biosystems Limited | Deoxyactagardine derivatives |
| GB0900599D0 (en) | 2009-01-14 | 2009-02-18 | Novacta Biosystems Ltd | Treatment |
| CN102388060B (zh) | 2009-02-04 | 2014-09-10 | 诺瓦克塔生物系统有限公司 | 阿肽加定衍生物 |
| EP2216937A1 (en) | 2009-02-10 | 2010-08-11 | Alcatel Lucent | Alarm notification between customer premises equipment and a remote management server |
-
2006
- 2006-01-17 GB GBGB0600928.6A patent/GB0600928D0/en not_active Ceased
-
2007
- 2007-01-17 WO PCT/GB2007/000138 patent/WO2007083112A2/en not_active Ceased
- 2007-01-17 MX MX2008009047A patent/MX2008009047A/es active IP Right Grant
- 2007-01-17 BR BRPI0706525-6A patent/BRPI0706525A2/pt active Search and Examination
- 2007-01-17 ES ES07704921T patent/ES2378090T3/es active Active
- 2007-01-17 US US12/161,221 patent/US7989416B2/en not_active Ceased
- 2007-01-17 KR KR1020087018136A patent/KR101573536B1/ko not_active Expired - Fee Related
- 2007-01-17 DK DK07704921.1T patent/DK1979375T3/da active
- 2007-01-17 AT AT07704921T patent/ATE534659T1/de active
- 2007-01-17 NZ NZ569486A patent/NZ569486A/en not_active IP Right Cessation
- 2007-01-17 CA CA002637315A patent/CA2637315A1/en not_active Abandoned
- 2007-01-17 JP JP2008550839A patent/JP5219837B2/ja not_active Expired - Fee Related
- 2007-01-17 EP EP07704921A patent/EP1979375B9/en not_active Not-in-force
- 2007-01-17 AU AU2007206769A patent/AU2007206769B2/en not_active Ceased
- 2007-01-17 PL PL07704921T patent/PL1979375T3/pl unknown
- 2007-01-17 PT PT07704921T patent/PT1979375E/pt unknown
- 2007-01-17 US US13/705,010 patent/USRE45003E1/en not_active Expired - Fee Related
- 2007-01-17 SI SI200730846T patent/SI1979375T1/sl unknown
- 2007-01-17 EP EP20100000424 patent/EP2189472A1/en not_active Withdrawn
- 2007-01-17 CN CN2007800067480A patent/CN101389641B/zh not_active Expired - Fee Related
-
2008
- 2008-06-25 IL IL192446A patent/IL192446A0/en unknown
-
2011
- 2011-06-10 US US13/157,454 patent/US8465947B2/en not_active Expired - Fee Related
-
2012
- 2012-02-17 CY CY20121100166T patent/CY1112559T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009523777A5 (https=) | ||
| US10774065B2 (en) | 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 | |
| JP6021805B2 (ja) | 腫瘍治療剤 | |
| EP1490355B1 (en) | Indolylmaleimide derivatives | |
| EP3724178B1 (en) | 1-(piperidinocarbonylmethyl)-2-oxopiperazine derivatives for treating cancer | |
| JP2007517807A5 (https=) | ||
| JP7458336B2 (ja) | γｃサイトカイン活性の調節 | |
| JP2023545396A5 (https=) | ||
| JP2006507265A5 (https=) | ||
| JP2003500404A5 (https=) | ||
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JPWO2003074045A1 (ja) | スルホンアミド含有複素環化合物及び血管新生抑制剤とを組み合わせてなる抗腫瘍剤 | |
| JP2011511075A5 (https=) | ||
| JP2006524669A5 (https=) | ||
| JP2021501756A5 (https=) | ||
| JP2006501201A5 (https=) | ||
| RU2002111866A (ru) | Производные N-замещенного индол-3-глиоксиламида - противоопухолевое лекарственное средство и средство, подавляющее ангиогенез (варианты), фармацевтическая композиция и противоопухолевое лекарственное средство (варианты) | |
| JP2005526794A5 (ja) | ベンズイミダゾールおよびマイトジェン活性化およびｒｈｏキナーゼ阻害剤としてのその使用 | |
| JP2003519137A5 (https=) | ||
| JP2017525717A5 (https=) | ||
| JP2006510606A5 (https=) | ||
| JP2014521620A5 (https=) | ||
| KR20210038366A (ko) | Flt3 저해제 및 mdm2 저해제를 포함하는 급성 골수성 백혈병 치료용 약학적 조성물 | |
| RU2007106933A (ru) | Ингибиторы hsp90 | |
| CN103025722B (zh) | 具有2-(杂芳基)氨基取代基的氯苯吩嗪及其抗微生物活性 |